Ario Pharma

Ario was engaged in developing new therapeutics for the treatment of pain, respiratory conditions and type II diabetes in cooperation with pharmaceutical partners.

The company’s assets have now either been acquired or licensed to pharma companies.

Alan O Connell.

Managed by

Alan O'Connell


We use cookies and analytics to improve your online experience and to help us to understand where our audience is and how they reach us, as well as to understand what topics and site features are of greatest interest.  To find out more, please read our Privacy Policy. By clicking on the Accept button, you consent to our use of cookies and browsing analytics.

Scroll to Top